Literature DB >> 19470970

Migraine and cardiovascular disease: possible mechanisms of interaction.

M E Bigal1, T Kurth, H Hu, N Santanello, R B Lipton.   

Abstract

Migraine, especially migraine with aura (MA), is an established risk factor for ischemic lesions of the brain. Recent evidence has also linked migraine to a broader range of ischemic vascular disorders including angina, myocardial infarction, coronary revascularization, claudication, and cardiovascular mortality. The mechanisms which link migraine to ischemic vascular disease remain uncertain and are likely to be complex. Cortical spreading depression, the presumed substrate of aura, may directly predispose to brain lesions and that would explain why MA is consistently demonstrated as a risk factor for cerebral ischemia, while for migraine without aura (MO), the evidence is less consistent. Additionally, individuals with migraine have a higher prevalence of risk factors known to be associated with cardiovascular disease (CVD), including hypertension, diabetes, and hyperlipidemia. The increased prevalence of CVD risk factors is also higher for MA than for MO. Since the evidence linking migraine and CVD is getting robust, neurologists should be aware of this association. Individuals with MO seem to be at little increased risk of CVD. MA is associated with an increased risk of ischemic stroke and likely also for other ischemic CVD events. Accordingly, heightened vigilance is recommended for modifiable cardiovascular risk factors in migraineurs, especially with MA. Ultimately, it will be important to determine whether MA is a modifiable risk factor for CVD and if preventive medications for migraine or antiplatelet therapy might reduce the risk of CVD in patients with MA.

Entities:  

Mesh:

Year:  2009        PMID: 19470970      PMCID: PMC2690985          DOI: 10.1212/WNL.0b013e3181a71220

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  59 in total

1.  What is the physiological role of the trigeminovascular system?

Authors:  P Goadsby
Journal:  Cephalalgia       Date:  1995-10       Impact factor: 6.292

2.  Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study.

Authors:  Leah R MacClellan; Braxton D Mitchell; John W Cole; Marcella A Wozniak; Barney J Stern; Wayne H Giles; David W Brown; Mary J Sparks; Steven J Kittner
Journal:  Genet Epidemiol       Date:  2006-11       Impact factor: 2.135

3.  Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

4.  Migraine and other headaches: associations with Rose angina and coronary heart disease.

Authors:  K M Rose; A P Carson; C P Sanford; P E Stang; C A Brown; A R Folsom; M Szklo
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

5.  Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.

Authors:  Andrew T Chan; JoAnn E Manson; Christine M Albert; Claudia U Chae; Kathryn M Rexrode; Gary C Curhan; Eric B Rimm; Walter C Willett; Charles S Fuchs
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

Review 6.  Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Authors:  David Dodick; Richard B Lipton; Vincent Martin; Vasilios Papademetriou; Wayne Rosamond; Antoinette MaassenVanDenBrink; Hassan Loutfi; K Michael Welch; Peter J Goadsby; Steven Hahn; Susan Hutchinson; David Matchar; Stephen Silberstein; Timothy R Smith; R Allan Purdy; Jane Saiers
Journal:  Headache       Date:  2004-05       Impact factor: 5.887

7.  Study of platelet activation in migraine: control by low doses of aspirin.

Authors:  G D'Andrea; M Toldo; A Cananzi; F Ferro-Milone
Journal:  Stroke       Date:  1984 Mar-Apr       Impact factor: 7.914

8.  C-reactive protein may be increased in migraine patients who present with complex clinical features.

Authors:  K M A Welch; Avery W Brandes; Lauren Salerno; Jan Lewis Brandes
Journal:  Headache       Date:  2006-02       Impact factor: 5.887

9.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

Review 10.  Current views of the risk of stroke for migraine with and migraine without aura.

Authors:  Tobias Kurth; Hans-Christoph Diener
Journal:  Curr Pain Headache Rep       Date:  2006-06
View more
  50 in total

1.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

Review 2.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

3.  Evaluation of right ventricle functions and serotonin levels during headache attacks in migraine patients with aura.

Authors:  Ezgi Kalaycıoğlu; Tayyar Gökdeniz; Ahmet Cağrı Aykan; Mustafa Ozan Gürsoy; Ilker Gül; Numan Ayhan; Sükrü Celik
Journal:  Int J Cardiovasc Imaging       Date:  2014-05-25       Impact factor: 2.357

Review 4.  Migraine as a potential risk factor for ischemic lesions: recent findings.

Authors:  Julio Pascual; Agustín Oterino
Journal:  Curr Pain Headache Rep       Date:  2009-10

5.  Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study.

Authors:  Tobias Kurth; Hans-Christoph Diener; Julie E Buring
Journal:  Cephalalgia       Date:  2011-06-14       Impact factor: 6.292

6.  Migraine and risk of incident diabetes in women: a prospective study.

Authors:  Rebecca C Burch; Pamela M Rist; Anke C Winter; Julie E Buring; Aruna D Pradhan; Elizabeth W Loder; Tobias Kurth
Journal:  Cephalalgia       Date:  2012-07-17       Impact factor: 6.292

7.  Headache and biomarkers predictive of vascular disease in a representative sample of US children.

Authors:  Karin B Nelson; Amanda Kalaydjian Richardson; Jianping He; Tarranum M Lateef; Suzan Khoromi; Kathleen R Merikangas
Journal:  Arch Pediatr Adolesc Med       Date:  2010-04

Review 8.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 9.  Migraine and cerebrovascular disease: still a dangerous connection?

Authors:  Elio Clemente Agostoni; Marco Longoni
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

10.  Risk of placental abruption in relation to migraines and headaches.

Authors:  Sixto E Sanchez; Michelle A Williams; Percy N Pacora; Cande V Ananth; Chungfang Qiu; Sheena K Aurora; Tanya K Sorensen
Journal:  BMC Womens Health       Date:  2010-10-26       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.